In this episode we speak with Hari Patel, Senior Director of Product and Portfolio Development, at BioMarin about innovation in rare diseases via gene therapy. Tune in to listen to his journey from Commercial to R&D side of the organization. We cover challenges in the gene therapy landscape and how BioMarin is addressing this high unmet need in multiple ways including working with patient advocacy groups to ensure that patients and their families are present at the right time and right place for clinical trials.
Recorded on April 19th, 2019.

Rare diseases and innovation in gene therapy

Slalom is a modern consulting firm focused on strategy, technology and business transformation. 
The Slalom Daily Dose shares the experience and perspectives of our healthcare and life sciences experts. We partner with clients to help them evolve their strategies, realize new opportunities and work through the challenges that they face. This series of thought pieces showcases our point-of-view on industry trends and events, market dynamics and approaches to problem solving.
Find our blogs and podcasts at https://medium.com/the-slalom-daily-dose.